FFA Sciences

Executive Summary

FFA Sciences is a Memphis-based biotechnology company specializing in novel fluorescent assay reagents for the rapid and sensitive measurement of unbound free fatty acids (FFAu). Founded in 2008, the company's core technology enables precise quantification of FFAu in biological samples, with primary applications in ophthalmology research and broader metabolomics. Operating as a specialized reagent and contract services provider, FFA Sciences serves the research community, offering tools to study metabolic pathways and ocular diseases. Despite its niche focus, the company has not disclosed funding rounds or revenue, and its stage remains unspecified, suggesting it may be in early commercialization or a bootstrapped growth phase. The private status and limited public information make it a speculative opportunity, but the technology addresses a specific need in metabolic and ophthalmic research, positioning it for potential partnerships or expansion if validation continues.

Upcoming Catalysts (preview)

• Q2 2026New Product Launch or Reagent Kit Release40% success
• Q3 2026Strategic Partnership with Ophthalmology Research Institution30% success
• Q4 2026Series A Funding or Grant Announcement25% success